Here's Why Integer (ITGR) is a Strong Momentum Stock

In this article:

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors.

While you may have an investing style you rely on, finding great stocks is made easier with the Zacks Style Scores. These are complementary indicators that rate stocks based on value, growth, and/or momentum characteristics.

Is This 1 Momentum Stock a Screaming Buy Right Now?

For momentum investors, upward or downward trends in a stock's price or earnings outlook take precedent, so they'll want to zero in on the Momentum Style Score. This Score can pinpoint good times to build a position in a stock, using factors like one-week price change and the monthly percentage change in earnings estimates.

Integer (ITGR)

Plano, TX-based Integer Holdings Corporation manufactures and develops medical devices and components primarily for original equipment manufacturers (OEMs).

ITGR sits at a Zacks Rank #2 (Buy), holds a Momentum Style Score of B, and has a VGM Score of A. The stock is up 0.4% and up 4.4% over the past one-week and four-week period, respectively, and Integer has gained 39.3% in the last one-year period as well. Additionally, an average of 192,002.75 shares were traded over the last 20 trading sessions.

A company's earnings performance is important for momentum investors as well. For fiscal 2023, two analysts revised their earnings estimate higher in the last 60 days for ITGR, while the Zacks Consensus Estimate has increased $0.02 to $4.62 per share. ITGR also boasts an average earnings surprise of 12%.

Investors should take the time to consider ITGR for their portfolios due to its solid Zacks Ranks, notable earnings metrics, and impressive Momentum and VGM Style Scores.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Integer Holdings Corporation (ITGR) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

Advertisement